Document:

Exchange Agreement

 Exhibit 10.35 
  
 [Execution Copy] 
  
  
 EXCHANGE AGREEMENT 
  
 THIS EXCHANGE AGREEMENT (this “Agreement”), dated as of
November 26, 2003 (the “Effective Date”), is made by and between Everspring Master Fund Ltd. (“Everspring”) and ViroPharma Incorporated (the “Company”). 
  
 Whereas, Everspring owns certain of the Company’s 6% Convertible
Subordinated Notes due March 1, 2007 (the “Notes”); and 
  
 Whereas, the Company wishes to offer shares of the Company’s common stock to Everspring in exchange for the Notes, and Everspring wishes to accept such offer, pursuant to the exemption from registration provided
by Section 3(a)(9) (“Section 3(a)(9)”) under the Securities Act of 1933, as amended (the “Securities Act”); 
  
 In consideration of the mutual promises contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows: 
  
 1.     Exchange; Exchange Date. On the terms and subject to the conditions set forth in this Agreement, on the Exchange Date (as defined below), the Company will deliver to Everspring shares (the
“Shares”) of the Company’s common stock, par value $.002 per share (the “Common Stock”), in exchange for Notes currently held by Everspring (the “Exchangeable Notes”) with an aggregate face
amount equal to one million dollars ($1,000,000) (subject to adjustment as provided herein, the “Aggregate Face Amount”). The exchange of Shares for Exchangeable Notes pursuant to this Agreement is referred to herein as the
“Exchange” and the date on which the Exchange occurs is referred to herein as the “Exchange Date”. 
  
 2.     Pricing Period; Pricing Notice. The Exchange Date shall occur on the second (2nd) Business Day immediately following the last Trading Day of the Pricing Period. “Pricing Period” means the period of fifteen (15)
consecutive Trading Days beginning on (and including) the Trading Day immediately following the Effective Date; provided, however, that Everspring shall have the right, during the Pricing Period, to notify the Company in writing that
it wishes to accelerate the Pricing Period (a “Pricing Notice”) and, upon delivery of a Pricing Notice to the Company, the term “Pricing Period” shall mean the period of five (5) consecutive Trading Days ending on
(and including) the date on which such notice is delivered. 

 3.     Exchange Ratio. (a) The number of Shares that the Company will deliver
to Everspring in exchange for the Exchangeable Notes shall be calculated using the following formula: 
  
 X = (Y) x (A/ B) 
     C 
  

	where:  	 	X   =   the number of Shares to be issued to Everspring; 

 Y   =   the Aggregate Face Amount; 
 A   =   $615 plus $9 (accrued
interest), or $624; 
 B   =   $1,000; and 
 C   =   the Exchange Price (as defined below). 
  
 In the event that any fractional Share would be issuable pursuant to the foregoing formula, the number of Shares issuable will be rounded up to the next
highest whole number. 
  
 (b) “Exchange Price”
means 90% of the average of the VWAPs for each of the Trading Days occurring during the Pricing Period; provided, however, that in no event shall the Exchange Price be lower than $2.46 (such amount subject to adjustment in the event of
a stock split, stock dividend or similar event). “VWAP” means the dollar volume-weighted average price for the Common Stock on the Nasdaq National Market (the “Principal Market”) during the period beginning at 9:30
a.m. (eastern time) and ending at 4:00 p.m. (eastern time) as reported by Bloomberg Financial Markets (“Bloomberg”) through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted
average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30 a.m. (eastern time) and ending at 4:00 p.m. (eastern time) as reported by Bloomberg, or, if no
dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink
sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.); provided, however, that the calculation of VWAP for a particular Trading Day shall exclude any block trade of ten thousand (10,000) shares or greater that
is executed on such day. “Trading Day” means any day during which the Principal Market is open for business and on which trading in the Common Stock on the Principal Market has not been suspended or otherwise curtailed or limited.
“Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks or the New York Stock Exchange are authorized or required by law to close in New York, New York. 
  
 (c) In the case of a dispute as to the number of Shares issuable pursuant to
the Exchange, or any component of such calculation, the Company shall issue to Everspring on the Exchange Date the number of Shares that are not disputed and at the same time shall submit the disputed calculations to a nationally-recognized
independent accounting firm selected mutually by the Company and Everspring within two (2) Business Days following the receipt by either party of written notice of any such dispute, provided that if the Company and Everspring are unable to agree on
such accounting firm within two (2) Business Days 
  

 -2- 

 following receipt of such notice, the Company shall promptly cause its independent accountants to select such accounting
firm. The Company and Everspring shall each use commercially reasonable efforts to cause such accountant to calculate the number of Shares issuable as provided herein and to notify the Company and Everspring of the results in writing no later than
two (2) Business Days following the day on which such accountant received the disputed calculations (the “Dispute Procedure”). Such accountant’s calculation shall be deemed conclusive absent manifest error. The fees of such
accountant shall be borne by the party whose calculations were most at variance with those of such accountant. 
  
 4.     Conditions to Exchange. (a) The obligation of the Company to deliver the Shares to Everspring pursuant to the Exchange
is subject to the satisfaction, as of the Exchange Date, of each of the following conditions, provided that such conditions are for the Company’s sole benefit and may be waived by the Company in its sole discretion: 
  
 (i)     the representations and
warranties of Everspring in this Agreement shall be true and correct as of the date when made and as of the Exchange Date as though made at that time (except for representations and warranties that speak as of a specific date); 
  
 (ii)     Everspring shall have performed,
satisfied and complied with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by Everspring at or prior to the Exchange Date; and 
  
 (iii)     Everspring shall have tendered
the Exchangeable Notes to the Company in the form required by this Agreement. 
  
 (b)     The obligation of Everspring hereunder to deliver the Exchangeable Notes to the Company pursuant to the Exchange is subject to the satisfaction, as of the Exchange Date, of each of the
following conditions, provided that such conditions are for Everspring’s sole benefit and may be waived by Everspring in its sole discretion: 
  
 (i)     the Common Stock shall be authorized for quotation on the Principal Market, trading in the Common Stock shall
not have been suspended by the Principal Market, and the Company shall not have received notice of any pending or threatened proceeding or other action to delist or suspend trading in the Common Stock; 
  
 (ii)     the representations and
warranties of the Company in this Agreement shall be true and correct as of the date when made and as of the Exchange Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Company
shall have performed, satisfied and complied with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company on or prior to the Exchange Date; 
  

 -3- 

 (iii)     Everspring shall have received the opinion of the
Company’s counsel dated as of the Exchange Date, in form, scope and substance reasonably satisfactory to Everspring and in substantially the form of Exhibit A attached hereto; 
  
 (iv)     the Company shall have delivered to Everspring the Shares in the form required
by this Agreement; 
  
 (v)    
the Company’s Board of Directors or a committee thereof shall have adopted resolutions approving this Agreement and the transactions contemplated hereby (the “Resolutions”), and the Resolutions shall be in full force and effect
and shall not have been amended or revised in any respect from the forms attached to the certificate delivered pursuant to clause (vii) below; 
  
 (vi)     the Company shall have delivered to Everspring a certificate evidencing the incorporation and good standing
of the Company issued by the state of its incorporation as of a recent date; and 
  
 (vii)     the Company shall have delivered to Everspring a certificate, executed by the Company’s Secretary or
Assistant Secretary, dated the Exchange Date, and attached to which shall be a certified copy of its Certificate of Incorporation, a copy of it Bylaws as currently in effect, and the Resolutions, such certificate to state that the Resolutions and
the Company’s Certificate of Incorporation and Bylaws are each in full force and effect on the Exchange Date, and have not been amended or revised in any respect from the forms attached thereto. 
  
 5.     Representations and Warranties of
Everspring. Everspring hereby represents and warrants to the Company as of the Effective Date and as of the Exchange Date (except for representations and warranties that speak as of a specific date), as follows: 
  
 (i)     Authorization;
Enforceability. Everspring has the requisite power and authority to enter into and perform this Agreement. The execution and delivery of this Agreement by Everspring and the consummation by it of the transactions contemplated hereby have
been duly authorized by all necessary corporate action. This Agreement constitutes a valid and binding obligation of Everspring enforceable against Everspring in accordance with its terms. 
  
 (ii)     Investment Intent.
Everspring is entering into this Agreement for its own account for investment purposes and not with a view to the distribution of the Shares, and has no present arrangement to sell the Shares to or through any person or entity; provided, however,
that by making such representations, Everspring does not agree to hold the Shares for any minimum or other specific term and reserves the right to dispose of the Shares, and to enter into other transactions with respect to the Shares, at any time in
accordance with federal and state securities laws applicable to such disposition or transaction. 
  

 -4- 

 (iii)     Ownership of Notes. Everspring owns the Exchangeable
Notes beneficially and of record, free and clear of any liens, claims or encumbrances incurred by or through Everspring, and has not paid to any person, directly or indirectly, any commission or other remuneration for soliciting the Exchange.

  
 (iv)     Ownership of
Company Common Stock. As of the date hereof, Everspring owns and, as of the Exchange Date and after giving effect to the transactions contemplated by this Agreement, including the receipt of the Shares, will own, beneficially and of record, less
than five percent (5%) of the number of shares of Common Stock then outstanding. 
  
 6.     Representations and Warranties of the Company. The Company hereby represents and warrants to Everspring as of the Effective Date and as of the Exchange Date (except for
representations and warranties that speak as of a specific date), and agrees with Everspring, as follows: 
  
 (i)     Due Incorporation. The Company is duly incorporated and in good standing under the laws of the State of
Delaware, and has all requisite corporate authority to own its properties and to carry on its business as now being conducted. 
  
 (ii)     Authorization; Enforceabilty. The Company has the power and authority to enter into and perform
its obligations under this Agreement, including without limitation, the power and authority to issue and deliver the Shares pursuant to the Exchange. The execution and delivery of this Agreement by the Company and the consummation by it of the
transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company, and no consent or authorization of any person or entity is required that has not been obtained prior to the Effective Date. This Agreement
constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (a) as rights to indemnification and contribution may be limited by federal or state securities laws and policies
underlying such laws and (b) as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium, liquidation or similar laws relating to, or affecting
generally, the enforcement of creditors’ rights and remedies. 
  
 (iii)     No Conflict. The terms of this Agreement, and the consummation of the transactions contemplated hereby, do not violate, contravene, conflict with or constitute a default or create
a lien, charge or encumbrance under any organizational documents of the Company, any agreements to which the Company is a party or to which its assets are bound, or any order or decree of any court or regulatory body. 
  
 (iv)     Reservation of Shares; Valid
Issuance; Preemptive Rights. The Company has duly and validly authorized and reserved for issuance to Everspring pursuant to the Exchange at least 253,659 shares of its Common Stock. When issued and delivered pursuant to the Exchange, and upon
receipt by the Company of the Exchangeable Notes, the Shares will be duly and validly issued, fully paid, and non- 
  

 -5- 

 assessable, free and clear of any liens, claims or encumbrances. Neither the Exchange nor the performance
by the Company of its obligations under this Agreement will trigger any preemptive, “poison-pill”, anti-takeover, anti-dilution, reset or other rights that would require the issuance of securities of the Company to any person. 

 
 (v)     Common Stock; Reporting
Requirements. The Common Stock is registered pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company’s Annual Report on Form 10-K for the year ended December 31, 2002, and all documents
filed by the Company pursuant to the reporting requirements of the Exchange Act since the date on which such Form 10-K was filed with the Securities and Exchange Commission, complied in all material respects with such requirements and the rules and
regulations promulgated thereunder. 
  
 (vi)     Listing. As of the Effective Date, the Common Stock (including the Shares) is listed and eligible for trading on the Nasdaq National Market; and the Company is in compliance in all material respects with
all continued listing requirements of such market. As of the Effective Date, the Company has not received any notice or inquiry from such market regarding any failure to comply with such listing requirements or the termination of the listing of the
Common Stock. 
  
 (vii)    
Non-Public Information. The Company has not disclosed any material non-public information to Everspring. 
  
 (viii)     No Broker. The Company has not paid to any person, directly or indirectly, any commission or other
remuneration for soliciting the Exchange. 
  
 (ix)     No Reliance. In entering into this Agreement, the Company (i) is not relying on any advice or representation of Everspring (other than the representations of Everspring contained herein), (ii) has not
received from Everspring any assurance or guarantee as to the merits (whether legal, regulatory, tax, financial or otherwise) of the Exchange or entering into this Agreement, (iii) has consulted with its own legal, regulatory, tax, business,
investment, financial and accounting advisors to the extent that it has deemed necessary, and (iv) has entered into this Agreement based on its own independent judgment and on the advice of its advisors as it has deemed necessary, and not on any
view (whether written or oral) expressed by Everspring. Everspring is not now nor has it ever been a financial advisor to, or other fiduciary with respect to, the Company. 
  
 (x)     Bankruptcy Protection. The Company has not taken any steps, and does not
currently expect to take any steps, to seek protection pursuant to 11 U.S.C. §§ 101 et seq. (the “Bankruptcy Code”) or any similar state bankruptcy law nor does the Company have any knowledge or reason to believe that its
creditors intend to initiate an involuntary proceeding under the Bankruptcy Code or any such state law. 
  
 (xi)     Solvency. To the Company’s knowledge, as of the Effective Date and, based upon fair and
reasonable estimates made by the Company, after giving effect to 
  

 -6- 

 the Exchange, (a) the fair value of the Company’s assets exceeds the current market value of its
liabilities, contingent or otherwise, as determined in accordance with generally accepted accounting principles, and (b) the Company reasonably anticipates that it is able to pay its debts as they mature. 
  
 7.     Agreements. The parties agree as follows:

  
 (i)     Issuance of
Shares. The issuance of the Shares pursuant to the Exchange shall be made in compliance with the provisions and requirements of Section 3(a)(9) and any applicable state securities law. 
  
 (ii)     Delivery of Notes. On the
Exchange Date, Everspring shall deliver the Exchangeable Notes to the Company by instructing its custodian to deliver such Notes to such account or accounts as the Company may specify in writing on or before the Business Day immediately preceding
the Exchange Date, and shall execute such documents and take such further action as may be reasonably necessary in order to transfer to the Company all right, title and interest to the Exchangeable Notes. 
  
 (iii)     Delivery of Shares;
Legends. On the Exchange Date, the Company shall deliver certificates representing the Shares to Everspring or, if Everspring so requests on or before the Business Day immediately preceding the Exchange Date, and provided the Company’s
transfer agent is then participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program, by crediting the Shares to Everspring’s or its designee’s account with DTC through its Deposit
Withdrawal Agent Commission system. Certificates evidencing the Shares issued on the Exchange Date shall be free of all restrictive or other legends. The Shares shall be freely tradable upon the issuance thereof pursuant to the Exchange, and the
Company shall, on or before the Exchange Date, notify its transfer agent that the Shares constitute freely tradable securities, and provide Everspring with written evidence of such notification. 
  
 (iv)     Listing of Common Stock.
The Company shall use commercially reasonable efforts to maintain the listing of the Common Stock (including the Shares) on the Principal Market while Everspring continues to hold any Shares. If the Company applies to have the Common Stock traded on
any other stock exchange or market, it will include the Shares in such application. 
  
 (v)     Termination and Cash Payment upon Certain Events. In the event that, for any reason within its control,
the Company fails to deliver the number of Shares to which Everspring is entitled hereunder, in freely tradable form in the manner provided herein, on or before the close of business on the third (3rd) Business Day immediately following the Exchange Date, Everspring may, at its option, terminate the Exchange by delivering written notice thereof to the
Company, in which event the Company will deliver to Everspring, on the first Business Day following the Company’s receipt of such notice, immediately available funds in an amount equal to 
  

 -7- 

 the Aggregate Face Amount multiplied by 624/1,000, against delivery of the Exchangeable Notes by
Everspring to the Company. 
  
 (vi)     Payment Set Aside. To the extent that the delivery of the Shares to Everspring pursuant to the Exchange, or any other payment made pursuant to this Agreement for or with respect to the Exchangeable Notes,
is declared to be fraudulent or preferential, set aside, recovered from, or otherwise restored to the Company or to a trustee, receiver or any other person or entity under any law (including, without limitation, any bankruptcy law, state or federal
law, common law or equitable cause of action), then, to the extent of any such restoration, the obligation or part thereof represented by the Exchangeable Notes to which such delivery or payment relates shall be revived and continued in full force
and effect as if such delivery had not been made or such enforcement or setoff had not occurred and, in such event, Everspring shall promptly return to the Company the Shares and any such payment. 
  
 8.     Miscellaneous.  
  
 (i)     Severability. In the event
that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that in such case the
parties shall negotiate in good faith to replace such provision. 
  
 (ii)     Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns of the parties.
Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement, except that the Company may assign this Agreement, and its rights and obligations hereunder, to the surviving company
in the event of a merger or consolidation involving the Company, and to the acquiring entity in the event of a sale of all or substantially all of the Company’s assets or other similar transaction. 
  
 (iii)     Governing Law;
Jurisdiction. This Agreement shall be governed by and construed under the laws of the State of Delaware applicable to contracts made and to be performed entirely within the State of Delaware. Each party hereby irrevocably submits to the
non-exclusive jurisdiction of the state and federal courts sitting in Wilmington, Delaware, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the
venue of such suit, action or proceeding is improper. In any claim or action commenced in connection with a dispute hereunder, the prevailing party shall be entitled to reimbursement of all reasonable legal fees and expenses. 
  

 -8- 

 (iv)     Counterparts. This Agreement may be executed in any
number of counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. A party may deliver executed copies of this Agreement to the other party by facsimile transmission.

  
 (v)     Headings.
The headings used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 
  
 (vi)     Other Definitional Provisions. All definitions contained in this Agreement are applicable equally to
the singular and plural forms of the terms defined. The words “hereof”, “herein” and “hereunder” and words of similar import referring to this Agreement refer to this Agreement as a whole and not to
any particular provision of this Agreement. 
  
 (vii)     Notices. Any notice, demand or request required or permitted to be given by either party pursuant to the terms of this Agreement shall be in writing and shall be deemed delivered (i) when delivered
personally or by verifiable facsimile transmission, unless such delivery is made on a day that is not a Business Day, in which case such delivery will be deemed to be made on the next succeeding Business Day, (ii) on the next Business Day after
timely delivery to an overnight courier and (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid), addressed as follows: 
  
 to Everspring: 
  
 767 Third Avenue, 38th Floor 
 New York, NY 10017 
 Attn: Brian Yeh/Ted Kalem 
 Fax: (212) 504-8264 
  
 with copy to: 
  
 Duval & Stachenfeld LLP 
 300 East 42nd Street 
 New York, NY 10017 
 Attn: Robert L. Mazzeo 
 Fax: (212) 883-8883 
  
 to the Company: 
  
 405 Eagleview Boulevard 
 Exton, PA 19341 
 Attn: Vincent Milano, Chief Financial Officer 
 Fax: (610) 458-7380 
  

 -9- 

 with copy to: 
  
 Thomas F. Doyle, Esq. 
 Vice President and General Counsel 
 ViroPharma Incorporated 
 405 Eagleview Boulevard 
 Exton, PA 19341 
 Fax: (610) 458-2017 
  
 A party may from time to time change its address for notices by giving at
least 10 days’ written notice of such changed address to the other party hereto. 
  
 (viii)     Entire Agreement; Amendments; No Agreement as to Future Exchanges. This Agreement constitutes the
entire agreement between the parties with regard to the subject matter hereof, superseding all prior agreements or understandings, whether written or oral, between or among the parties. Except as expressly provided herein, neither this Agreement nor
any term hereof may be amended except pursuant to a written instrument executed by Everspring and the Company, and no provision hereof may be waived other than by a written instrument signed by the party against whom enforcement of any such waiver
is sought. The parties acknowledge that no agreement or understanding currently exists between them with regard to any exchanges of securities other than the Exchange. 
  
 (ix)     No Strict Construction. The language used in this Agreement is and will
be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 
  
 (x)     Expenses. The Company and Everspring each shall pay all costs and expenses that it incurs in connection
with the negotiation, execution, delivery and performance of this Agreement. 
  
 (xi)     Confidentiality. Each party (the “Receiving Party”) agrees (i) to keep all Confidential Information (as defined below) that it receives from the other party (the
“Transmitting Party”) strictly confidential, (ii) not to disclose any such Confidential Information to any third party other than employees and agents of the Receiving Party who have a need to know such Confidential Information for
the purpose of effecting the Exchange and who have been made aware of the confidentiality obligations imposed hereby, and (iii) not to use any such Confidential Information except in connection with the Exchange. “Confidential
Information” means all non-public information that Disclosing Party designates as being confidential or that under the circumstances surrounding the disclosure thereof would reasonably be considered to constitute Confidential Information of
the Disclosing Party, but shall not include any information that (i) is or subsequently becomes publicly available without a breach by Receiving Party, or any of its employees, agents or affiliates, of any obligation owed Disclosing Party or (ii)
became known to Receiving Party prior to Disclosing Party’s disclosure of such information to 
  

 -10- 

 Receiving Party as shown by Receiving Party’s written records. Notwithstanding the foregoing,
Receiving Party may disclose Confidential Information to the extent required to be disclosed by law, rule, regulation, administrative or legal process. 
  
  
  
 [Signature Page to Follow] 
  

 -11- 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the
date first written above. 
  
  

			
	VIROPHARMA INCORPORATED
		
	By:	 	/S/     VINCENT J. MILANO
	 	 	

	 	 	Name: Vincent J. Milano
	 	 	Title: Chief Financial Officer
	
	EVERSPRING MASTER FUND LTD.
		
	By:	 	/S/     THEODORE E. KALEM
	 	 	

	 	 	Name: Theodore E. Kalem
	 	 	Title: Managing Member
	 	 	Its:

  

 -12-Amendment to Employment Agreement re: Mr. Kellogg

 EXHIBIT 10.21 
  
 AMENDMENT TO 
 EMPLOYMENT AGREEMENT 
  
 This Amendment to the
April 30, 1992 Employment Agreement (the “Agreement”) between KOHL’S DEPARTMENT STORES, INC., a Delaware corporation (“Company”), and WILLIAM S. KELLOGG (“Executive”) is made as of this 31st day of January, 2004.

  
 1. Executive and Company hereby agree that Section 7.3 of the Agreement is
amended to read, in its entirety, as follows: 
  
 7.3. Health Insurance. At all times during the term of this Agreement, the Executive shall be provided with health insurance and a supplemental executive medical plan with coverage for Executive and Executive’s Eligible
Dependants (as defined in such insurance and medical plans), substantially the same as that covering the Executive and Executive’s Eligible Dependants as of the date of this Agreement (collectively the “Health Insurance Benefits”).
Throughout the term of this Agreement, Executive shall pay a portion of the premiums for the Health Insurance Benefits at a rate which shall not exceed the rate paid by other Company executives. 
  
 Notwithstanding anything contained herein to the contrary, in the event the
Executive’s employment with the Company is terminated at the expiration of the Employment Term or for any reason other than (A) a termination for Cause, or (B) a voluntary termination by the Executive for any reason other than “Good
Reason” or other than approved by the Board of Directors of the Company, the Company shall continue to provide Executive and Executive’s Eligible Dependents with the Health Insurance Benefits. In the event of Executive’s death, the
Health Insurance Benefits shall continue to be provided to Executive’s Eligible Dependants, in each case for as long as each individual would have continued to qualify as an “Eligible Dependant” under the terms of the applicable
insurance and medical plans had Executive been living, provided: 
  

	 	(1)	the Health Insurance Benefits are reasonably available to the Company with respect to Executive and Executive’s Eligible Dependants, as the case may be; and

  

	 	(2)	from and after the date of this Amendment, Executive or Executive’s Eligible Dependants, as the case may be, shall reimburse the Company for all premiums paid for
Executive’s retiree Health Insurance Benefits, as determined by the Company in good faith from time to time. The Company shall provide Executive a quarterly invoice for such reimbursement, and amounts due hereunder may be withheld from other
amounts payable to Executive. 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date set forth above.

  

									
	 EXECUTIVE:
	 	 	 	 KOHL’S DEPARTMENT STORES, INC.

				
	 /s/    William S. Kellogg
	 	 	 	By:	 	 /s/    R. Lawrence Montgomery

	
	 	 	 	 	 	

	 William S. Kellogg
	 	 	 	 	 	            R. Lawrence Montgomery

	 	 	 	 	 	 	            Chairman, Chief Executive Officer

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]